Biopsy needle advancement during bone marrow aspiration increases mesenchymal stem cell concentration
Point-of-care kits to concentrate bone marrow (BM) derived mesenchymal stem cells (MSCs) are used clinically in horses.A maximal number of MSCs per ml of marrow aspirated might be desired prior to use of a point-of-care system to concentrate MSCs.Our objective was to test a method to increase the number of MSCs per ml of marrow collected.We collect